ArticleCase reports in orthopedics2026
Rare Case of Sclerosing Epithelioid Fibrosarcoma of the Thoracic Spine.
Article in Case reports in orthopedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rare Case of Sclerosing Epithelioid Fibrosarcoma of the Thoracic Spine.Case reports in orthopedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sclerosing epithelioid fibrosarcoma (SEF) is a rare sarcomatous tumor that presents infrequently as an osseous lesion of the spine. To our knowledge, few case reports exist regarding primary lesions of the lumbar spine, with only one report indicating the thoracic spine as a primary site. Case Description: We present a case of a 32-year-old female presenting with primary osseous SEF with complaints of axial and right-sided thoracic back pain for 4 months. Imaging of the thoracic spine revealed a mass at T5 with vertebra plana and central spinal cord compression at T5-T6 without significant expansion of mass to soft tissues or adjacent vertebral levels. We performed a T5 corpectomy with posterior spinal instrumented fusion from T3 to T7. Pathologic and immunohistochemical studies confirmed the diagnosis of SEF. One-year follow-up revealed no recurrence of disease and significant pain relief without neurologic dysfunction. Conclusions: In light of the extent of the vertebral body involvement, the severity of cord compression, and the patient's associated neurologic symptoms, a T5 corpectomy with T3-T7 posterior fusion was performed. Given the nature of the spine, complete resection of these tumors is usually impossible, and adjuvant radiation or chemotherapy may be necessary for resolution of disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.